March 2, 2022 

Direct-Acting Antivirals for HCV Greatly Reduce Healthcare Utilization

Chronic hepatitis C patients might take direct-acting antiviral (DAA) medications for only a few months, but the benefits can last much, much longer. A recent study finds hepatitis C virus (HCV) patients treated with the therapy dramatically reduce their visits to hospitals or emergency departments for liver- and nonliver-related conditions. Find out how beneficial DAAs were. Read more.


Inflammatory Syndrome Rare in Children After COVID-19 Vaccine

While frightening for parents, especially when first reported in the spring of 2020, multisystem inflammatory syndrome in children was uncommon after COVID-19. A review of cases reported to public health officials found that it appears to be especially rare after vaccination against SARS-CoV-2. Learn more about how cases were affected by vaccination against SARs-CoV-2 infection.

PPI Discontinuation Should Be Considered in Many Cases

Proton pump inhibitors (PPIs) are very widely prescribed, and the American Gastrointestinal Association is concerned that the drugs—designed to prevent acid-mediated upper-gastrointestinal conditions— are often used in less beneficial situations. That is why an expert review suggests that deprescribing should be considered in many cases. Find out what criteria they recommend and best practices for accomplishing discontinuation of PPIs.


Identifying High-Volume Antibiotic Prescribers Can Aid Stewardship

Pharmacists often find themselves filling antibiotic prescriptions written by the same clinicians over and over. That's not surprising, because a new CDC study found that just 10% of prescribers are writing more than 40% of the scripts. Now, public health officials have found additional ways to identify who is overusing the drugs and to target them for antibiotic stewardship intervention. Read more.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -